Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Immunity

Volumn 37, Issue 3, 2012, Pages 574-587

  Lynch, Lydia ^a,b,d   Nowak, Michael ^a   Varghese, Bindu ^a   Clark, Justice ^a   Hogan, Andrew E ^b   Toxavidis, Vasillis ^a   Balk, Steven P ^a   O'Shea, Donal ^b,c   O'Farrelly, Cliona ^d   Exley, Mark A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOCYLCERAMIDE; CERAMIDE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; LEPTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MACROPHAGE; MALE; METABOLIC DISORDER; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADOPTIVE TRANSFER; ADULT; ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD1D; CYTOKINES; DIET, HIGH-FAT; FEMALE; FLOW CYTOMETRY; HUMANS; LIVER; LYMPHOCYTE COUNT; MACROPHAGES; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; MIDDLE AGED; NATURAL KILLER T-CELLS; OBESITY; SPLEEN; YOUNG ADULT;

EID: 84866520055     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.06.016     Document Type: Article

References (56)

1. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
2. Berzins S.P., Smyth M.J., Baxter A.G. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 2011, 11:131-142.
3. Brigl M., Brenner M.B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004, 22:817-890.
4. Cerundolo V., Silk J.D., Masri S.H., Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 2009, 9:28-38.
5. Dalmas E., Clément K., Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol. 2011, 32:307-314.
6. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat. Genet. 2000, 26:13.
7. Elinav E., Pappo O., Sklair-Levy M., Margalit M., Shibolet O., Gomori M., Alper R., Thalenfeld B., Engelhardt D., Rabbani E., Ilan Y. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J. Pathol. 2006, 209:121-128.
8. Exley M.A., Bigley N.J., Cheng O., Shaulov A., Tahir S.M., Carter Q.L., Garcia J., Wang C., Patten K., Stills H.F., et al. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 2003, 110:519-526.
9. Exley M.A., Lynch L., Varghese B., Nowak M., Alatrakchi N., Balk S.P. Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects. Clin. Immunol. 2011, 140:184-195.
10. Fantuzzi G., Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 2000, 68:437-446.
11. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
12. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., Vasan R.S., Murabito J.M., Meigs J.B., Cupples L.A., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
13. Fox L.M., Cox D.G., Lockridge J.L., Wang X., Chen X., Scharf L., Trott D.L., Ndonye R.M., Veerapen N., Besra G.S., et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 2009, 7:e1000228.
14. Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., Tsuneyama K., Nagai Y., Takatsu K., Urakaze M., et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009, 58:2574-2582.
15. Gregor M.F., Hotamisligil G.S. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res. 2007, 48:1905-1914.
16. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9:367-377.
17. Gumperz J.E. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance. Traffic 2006, 7:2-13.
18. Hong E.G., Ko H.J., Cho Y.R., Kim H.J., Ma Z., Yu T.Y., Friedline R.H., Kurt-Jones E., Finberg R., Fischer M.A., et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009, 58:2525-2535.
19. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
20. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008, 8:923-934.
21. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
22. Ji Y., Sun S., Xu A., Bhargava P., Yang L., Lam K.S., Gao B., Lee C.H., Kersten S., Qi L. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J. Biol. Chem. 2012, 287:13561-13571.
23. Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.H., Benoit L.A., Byers D.E., Alevy Y., Tucker J., et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 2008, 14:633-640.
24. Kotas M.E., Lee H.Y., Gillum M.P., Annicelli C., Guigni B.A., Shulman G.I., Medzhitov R. Impact of CD1d deficiency on metabolism. PLoS ONE 2011, 6:e25478.
25. Kronenberg M., Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002, 2:557-568.
26. Lönn M., Mehlig K., Bengtsson C., Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J. 2010, 24:326-331.
27. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184.
28. Lynch L., O'Shea D., Winter D.C., Geoghegan J., Doherty D.G., O'Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 2009, 39:1893-1901.
29. Ma X., Hua J., Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J. Hepatol. 2008, 49:821-830.
30. Macia L., Delacre M., Abboud G., Ouk T.S., Delanoye A., Verwaerde C., Saule P., Wolowczuk I. Impairment of dendritic cell functionality and steady-state number in obese mice. J. Immunol. 2006, 177:5997-6006.
31. Mantell B.S., Stefanovic-Racic M., Yang X., Dedousis N., Sipula I.J., O'Doherty R.M. Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS ONE 2011, 6:e19831.
32. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.R., Koezuka Y., Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000, 192:741-754.
33. Matsuda J.L., Mallevaey T., Scott-Browne J., Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 2008, 20:358-368.
34. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
35. Medrikova D., Jilkova Z.M., Bardova K., Janovska P., Rossmeisl M., Kopecky J. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Int J Obes (Lond) 2012, 36:262-272.
36. Monteiro M., Almeida C.F., Caridade M., Ribot J.C., Duarte J., Agua-Doce A., Wollenberg I., Silva-Santos B., Graca L. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J. Immunol. 2010, 185:2157-2163.
37. Nishimura S., Manabe I., Nagasaki M., Seo K., Yamashita H., Hosoya Y., Ohsugi M., Tobe K., Kadowaki T., Nagai R., Sugiura S. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J. Clin. Invest. 2008, 118:710-721.
38. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
39. Nowak M., Lynch L., Yue S., Ohta A., Sitkovsky M., Balk S.P., Exley M.A. The A2aR adenosine receptor controls cytokine production in iNKT cells. Eur. J. Immunol. 2010, 40:682-687.
40. O'Connell J., Lynch L., Cawood T.J., Kwasnik A., Nolan N., Geoghegan J., McCormick A., O'Farrelly C., O'Shea D. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS ONE 2010, 5:e9997.
41. Ohmura K., Ishimori N., Ohmura Y., Tokuhara S., Nozawa A., Horii S., Andoh Y., Fujii S., Iwabuchi K., Onoé K., Tsutsui H. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30:193-199.
42. Pellicci D.G., Hammond K.J., Uldrich A.P., Baxter A.G., Smyth M.J., Godfrey D.I. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 2002, 195:835-844.
43. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
44. Satoh M., Andoh Y., Clingan C.S., Ogura H., Fujii S., Eshima K., Nakayama T., Taniguchi M., Hirata N., Ishimori N., et al. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS ONE 2012, 7:e30568.
45. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
46. Speak A.O., Salio M., Neville D.C., Fontaine J., Priestman D.A., Platt N., Heare T., Butters T.D., Dwek R.A., Trottein F., et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 2007, 104:5971-5976.
47. Swann J.B., Coquet J.M., Smyth M.J., Godfrey D.I. CD1-restricted T cells and tumor immunity. Curr. Top. Microbiol. Immunol. 2007, 314:293-323.
48. Tiemessen M.M., Jagger A.L., Evans H.G., van Herwijnen M.J., John S., Taams L.S. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 2007, 104:19446-19451.
49. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
50. Wentworth J.M., Naselli G., Brown W.A., Doyle L., Phipson B., Smyth G.K., Wabitsch M., O'Brien P.E., Harrison L.C. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010, 59:1648-1656.
51. Williams L.M., Ricchetti G., Sarma U., Smallie T., Foxwell B.M. Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 2004, 113:281-292.
52. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15:921-929.
53. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.
54. Wu L., Van Kaer L. Natural killer T cells and autoimmune disease. Curr. Mol. Med. 2009, 9:4-14.
55. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
56. Yang L., Jhaveri R., Huang J., Qi Y., Diehl A.M. Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. Lab. Invest. 2007, 87:927-937.